All Relations between Haloperidol and dopamine

Publication Sentence Publish Date Extraction Date Species
M Gearing, E Terasaw. The alpha-1-adrenergic neuronal system is involved in the pulsatile release of luteinizing hormone-releasing hormone in the ovariectomized female rhesus monkey. Neuroendocrinology. vol 53. issue 4. 1991-07-15. PMID:1646417. the effects of prazosin (an alpha 1-antagonist), rauwolscine (an alpha 2-antagonist), propranolol (a beta-antagonist), haloperidol (a dopamine antagonist), sch23390 (a d1 antagonist), and ly163502 (a d2 agonist), on in vivo lhrh release in the stalk-median eminence were tested in ovariectomized female rhesus monkeys using push-pull perfusion. 1991-07-15 2023-08-11 monkey
W Löscher, D Hönac. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors. The Journal of pharmacology and experimental therapeutics. vol 257. issue 3. 1991-07-12. PMID:1675288. furthermore, these behavioural effects were attenuated or blocked by the dopamine antagonist haloperidol and the alpha-1 adrenoceptor antagonist, prazosin. 1991-07-12 2023-08-11 rat
H E Shannon, K G Bemis, S C Peter. Effects of oral pergolide mesylate on nociceptive spinal cord reflexes in rats. Life sciences. vol 48. issue 23. 1991-07-12. PMID:2046457. the effects of pergolide were blocked by haloperidol, demonstrating that the effects of pergolide were mediated through dopamine receptors. 1991-07-12 2023-08-11 rat
S Yamada, H Yokoo, S Harajiri, S Nish. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol. European journal of pharmacology. vol 192. issue 1. 1991-07-08. PMID:2040357. alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol. 1991-07-08 2023-08-11 rat
S Yamada, H Yokoo, S Harajiri, S Nish. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol. European journal of pharmacology. vol 192. issue 1. 1991-07-08. PMID:2040357. the effects of chronic treatment with haloperidol on spontaneous and electrically evoked dopamine (da) release from striatal slices of rats were investigated in vitro. 1991-07-08 2023-08-11 rat
T Schneider, E Zrenne. Effects of D-1 and D-2 dopamine antagonists on ERG and optic nerve response of the cat. Experimental eye research. vol 52. issue 4. 1991-07-03. PMID:2037020. various concentrations of three dopamine antagonists (fluphenazine, haloperidol and sulpiride) with different affinities to the receptor subtypes were applied in order to test their effect on responses from outer (isolated piii-component of the erg), middle (b-wave) and inner (optic nerve response, onr) retinal layers, recorded from dark-adapted, isolated, arterially-perfused cat eyes. 1991-07-03 2023-08-11 cat
S L'Héreault, N Barde. Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus. Brain research. Molecular brain research. vol 9. issue 4. 1991-06-28. PMID:1710012. haloperidol and the selective d2 antagonist (+)-butaclamol prevented the inhibitory effects of both dopamine and the selective d2 agonist, 2-bromo-alpha-ergocryptine. 1991-06-28 2023-08-11 rat
P Huettl, G A Gerhardt, M D Browning, J M Masseran. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells. The Journal of pharmacology and experimental therapeutics. vol 257. issue 2. 1991-06-24. PMID:1674528. the inhibitory effect of the selective dopamine d2 agonist pergolide on catecholamine release from the chromaffin cells was not reversed by 10(-6) m concentrations of the selective dopamine d2 receptor antagonists haloperidol, domperidone, metaclopramide, fluphenazine, flupentixol, (+)- or (-)-sulpiride, the dopamine d1 receptor antagonist sch 23390 (10(-7) m) or the alpha receptor antagonist phentolamine (10(-6) m). 1991-06-24 2023-08-11 cattle
K Yamaguchi, H Ham. Participation of periventricular dopamine receptors in vasopressin secretion elicited by hypertonicity of systemic blood in rats. Acta endocrinologica. vol 124. issue 4. 1991-06-14. PMID:2031443. the avp response to 0.75 mumol dopamine was blocked by its antagonists, sch 23390, sulpiride and haloperidol, given intracerebroventricularly at a dose of 0.15 mumol 10 or 40 min before the injection of dopamine. 1991-06-14 2023-08-11 rat
E C Essig, I C Kilpatric. Haloperidol-induced increases in rat amygdaloid dopamine metabolism: evidence for independence from postsynaptic feedback mechanisms. Neuroscience letters. vol 123. issue 2. 1991-06-12. PMID:2027541. the present study assessed the role of postsynaptic dopamine (da) receptors in mediating the actions of focal injections of the classical antipsychotic drug, haloperidol, on da metabolism in the rat amygdala (amyg) and caudate-putamen (cp) using a high-performance liquid chromatographic assay. 1991-06-12 2023-08-11 rat
S Mak. [Effects of electrical or chemical stimulation of the prefrontal cortex on arrhythmias induced in cats by electrical stimulation of the anteromedial hypothalamus]. Fukuoka igaku zasshi = Hukuoka acta medica. vol 82. issue 2. 1991-06-05. PMID:2022364. when dopamine or noradrenaline was microinjected into the site of prefrontal cortex where psa was inhibited, psa was suppressed and this effect was blocked by microinjection of haloperidol or phenoxybenzamine, respectively. 1991-06-05 2023-08-11 cat
S Seth, D Mukherjee, A K Choudhary, J N Sinha, S Gurt. Opioid and non-opioid central cardiovascular effects of ketamine. Naunyn-Schmiedeberg's archives of pharmacology. vol 342. issue 5. 1991-06-03. PMID:1965327. the cardiovascular response elicited by the low dose was naloxone insensitive and completely blocked by haloperidol, but not by dopamine antagonist pimozide. 1991-06-03 2023-08-11 Not clear
B A McMillen, S M Scott, H L William. Effects of subchronic amphetamine or amfonelic acid on rat brain dopaminergic and serotonergic function. Journal of neural transmission. General section. vol 83. issue 1-2. 1991-05-28. PMID:2018630. both drugs produced hypersensitivity, but the cataleptic response to acute dopamine (da) receptor blockade by haloperidol was unaltered. 1991-05-28 2023-08-11 rat
J D Salamone, M J Zigmond, E M Stricke. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience. vol 39. issue 1. 1991-05-24. PMID:2128534. systemic administration of 0.2 mg/kg of the dopamine antagonist haloperidol reduced the rate of feeding in food-deprived rats, whereas a dose of 0.4 mg/kg suppressed both the rate of feeding and time spent feeding. 1991-05-24 2023-08-11 rat
M J Fargeas, J Fioramonti, L Buen. Involvement of dopamine in the central effect of neurotensin on intestinal motility in rats. Peptides. vol 11. issue 6. 1991-05-23. PMID:2087439. the central effect of nt on the fed pattern involved dopaminergic neurons as it was mimicked by dopamine, blocked by haloperidol and partly antagonized by either sulpiride or (+) sch 23390. 1991-05-23 2023-08-11 rat
C W Schindler, S R Tella, J M Witkin, S R Goldber. Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys. Life sciences. vol 48. issue 16. 1991-05-21. PMID:2016988. the dopamine d2 antagonist haloperidol (0.1 mg/kg i.m.) 1991-05-21 2023-08-11 monkey
Y Umeda, T Sum. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol. European journal of pharmacology. vol 191. issue 2. 1991-05-21. PMID:2086236. decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol. 1991-05-21 2023-08-11 rat
Y Umeda, T Sum. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol. European journal of pharmacology. vol 191. issue 2. 1991-05-21. PMID:2086236. the release of endogenous da (dopamine) and dopac (3,4-dihydroxyphenylacetic acid) from rat striatal slices was measured after withdrawal from a prior long-term treatment of the rat with haloperidol to investigate adaptive changes in striatal da and dopac release induced by chronic haloperidol treatment. 1991-05-21 2023-08-11 rat
R C Smallridge, F E Carr, H G Fei. Diisopropylfluorophosphate (DFP) reduces serum prolactin, thyrotropin, luteinizing hormone, and growth hormone and increases adrenocorticotropin and corticosterone in rats: involvement of dopaminergic and somatostatinergic as well as cholinergic pathways. Toxicology and applied pharmacology. vol 108. issue 2. 1991-05-17. PMID:1673267. tsh suppression was partially reversed by immunoneutralization with somatostatin antibody, and prl suppression was completely prevented by a dopamine antagonist (haloperidol). 1991-05-17 2023-08-11 rat
C H Shue, C J Che. The excitatory effect of dopamine on isolated canine tracheal smooth muscle. The Journal of pharmacy and pharmacology. vol 42. issue 10. 1991-05-16. PMID:1982149. both a dopaminergic antagonist, haloperidol (10(-5) and 10(-4)m), and an alpha-adrenoceptor antagonist, phentolamine (10(-7) to 10(-5)m), attenuated the contraction to 10(-3)m dopamine. 1991-05-16 2023-08-11 Not clear